What are common smoking cessation medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Smoking Cessation Medications

The most effective first-line smoking cessation medications include nicotine replacement therapy (NRT), bupropion SR, and varenicline, with combination NRT and varenicline showing the highest cessation rates. 1

First-Line Pharmacotherapies

Nicotine Replacement Therapy (NRT)

  • Available in multiple forms: patches, gum, lozenges, inhalers, and nasal spray 1
  • Works by providing nicotine to reduce withdrawal symptoms while eliminating exposure to other harmful chemicals in tobacco 1
  • Using combination NRT (particularly a nicotine patch plus a rapid-delivery form like gum or lozenge) is more effective than single NRT products 1
  • Long-term nicotine patch therapy (>14 weeks) appears superior to shorter-term treatment 1
  • Common side effect: Local irritation at application site; epistaxis with nasal spray 1

Varenicline (Chantix)

  • Partial agonist at α4β2 nicotinic acetylcholine receptors that reduces cravings and blocks rewarding effects of smoking 1, 2
  • Recommended dosing: Start 1-2 weeks before quit date, titrate from 0.5 mg once daily (days 1-3), to 0.5 mg twice daily (days 4-7), to target dose of 1 mg twice daily for 12 weeks 1, 2
  • Most effective single agent with cessation rates of approximately 28% compared to 12% with placebo 1, 3
  • Common side effect: Nausea (most common adverse effect) 1
  • Requires monitoring for neuropsychiatric symptoms, though recent evidence suggests these risks may be lower than previously thought 1

Bupropion SR (Zyban)

  • Atypical antidepressant that inhibits norepinephrine and dopamine reuptake 4
  • Recommended dosing: Start 1-2 weeks before quit date, 150 mg once daily for 3 days, then 150 mg twice daily for 7-12 weeks 1
  • Increases cessation rates to approximately 19% compared to 11% with placebo 3
  • Common side effects: Insomnia, dry mouth; rare but serious risk of seizures (contraindicated in patients with seizure disorders) 1
  • Contraindicated in patients with seizure risk, those taking MAO inhibitors, or those with closed-angle glaucoma 1

Second-Line Medications

  • Nortriptyline: Tricyclic antidepressant shown to be effective for smoking cessation (25-50 mg/day) 1, 5
  • Clonidine: Antihypertensive medication that can aid smoking cessation but has more side effects 1
  • Cytisine: A partial nicotine receptor agonist available in some European countries 1

Combination Therapies

  • Combination NRT (patch plus short-acting form) has shown the highest cessation rates of approximately 31.5% 3
  • Bupropion plus nicotine patch appears superior to bupropion alone 1
  • Adding behavioral support to pharmacotherapy significantly increases cessation rates from 18% to 21% 1

Comparative Effectiveness

  • Varenicline appears more effective than bupropion or NRT monotherapy 3, 4
  • Combination NRT shows comparable effectiveness to varenicline 3
  • Both varenicline and combination NRT are more effective than single NRT products or bupropion alone 3

Common Pitfalls and Caveats

  • Inadequate duration of therapy: Most pharmacotherapies should be used for at least 8-12 weeks 1
  • Insufficient dosing: Higher-dose NRT may be needed for heavy smokers 1
  • Failure to combine behavioral counseling with pharmacotherapy: Combined approaches significantly increase success rates 1, 6
  • Premature discontinuation due to side effects: Most side effects are mild and diminish over time 1
  • Not considering combination therapy for patients who fail monotherapy 1
  • Overlooking the need for extended treatment in some patients to prevent relapse 1

Selection Algorithm

  1. For most patients: Start with varenicline or combination NRT (patch plus short-acting form) as these have the highest success rates 3, 4
  2. For patients with psychiatric history or concerns about varenicline: Consider combination NRT or bupropion 1
  3. For patients with seizure risk: Avoid bupropion; use NRT or varenicline 1
  4. For patients who failed previous quit attempts with one medication: Try an alternative first-line medication or combination therapy 1
  5. For patients with high nicotine dependence: Consider combination therapy from the start 1

Remember that the success rate of smoking cessation increases significantly when pharmacotherapy is combined with behavioral counseling interventions 1, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Smoking cessation pharmacotherapy; varenicline or bupropion?

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2024

Research

Antidepressants for smoking cessation.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.